Study of RE.DOCTOR Vitals® Software Accuracy

Launched by RE.DOCTOR LLC · Jan 23, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the accuracy of a digital health monitoring software called RE.DOCTOR Vitals®, which uses a technology called Photoplethysmography (PPG) to collect information about your heart and other bodily functions. By gathering a large amount of data from PPG waveforms along with traditional health measurements, the researchers hope to improve how well the software can predict important health indicators like blood sugar levels, blood pressure, and heart rate. This could lead to better health monitoring for people with respiratory disorders, cardiovascular diseases, and diabetes.

To participate in the trial, you need to be between 13 and 80 years old and have a smartphone that can run the study app. Participants will continuously monitor their health using this app and allow researchers to collect data about their PPG waveforms in various settings. It’s important to note that you should not have any serious heart conditions or be on certain medications that could affect the results. As the study is not yet recruiting, this is a chance for those interested in helping improve digital health tools for many people.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 13-80 years.
• • Ownership of a smartphone compatible with the designated data collection application.
• • Willingness to use the smartphone application for continuous PPG data collection.
• • Ability to provide informed consent for participation in the study.
• • No known history of conditions or medications that significantly affect PPG waveforms (e.g., severe arrhythmias, use of beta-blockers).
• • Healthy individuals and individuals with diagnosed CVD diseases, individuals with diagnosed pre-diabetes, diabetes I, diabetes II
• Exclusion Criteria:
• • Age outside the specified range of 13-80 years.
• • Lack of ownership of a compatible smartphone.
• • Inability or unwillingness to use the designated smartphone application for data collection.
• • Known history of severe arrhythmias or use of medications affecting cardiovascular function.
• • Any condition that, in the judgment of the investigator, may compromise the participant's ability to complete the study.